Knights Of Columbus Asset Advisors LLC Viridian Therapeutics, Inc.\De Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.48 Billion
- Q3 2024
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 57,565 shares of VRDN stock, worth $1.15 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
57,565
Previous 79,974
28.02%
Holding current value
$1.15 Million
Previous $1.04 Million
25.87%
% of portfolio
0.09%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding VRDN
# of Institutions
182Shares Held
76.9MCall Options Held
581KPut Options Held
439K-
Black Rock Inc. New York, NY4.77MShares$95.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$88.1 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$77.4 Million9.15% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.75MShares$74.8 Million3.15% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.45MShares$68.7 Million12.74% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $795M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...